Browse > Article
http://dx.doi.org/10.4062/biomolther.2021.119

Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors  

Paudel, Suresh (College of Pharmacy, Chonnam National University)
Wang, Shuji (College of Pharmacy, Chonnam National University)
Kim, Eunae (College of Pharmacy, Chosun University)
Kundu, Dooti (College of Pharmacy, Chonnam National University)
Min, Xiao (College of Pharmacy, Chonnam National University)
Shin, Chan Young (Department of Pharmacology and Department of Advanced Translational Medicine, School of Medicine, Konkuk University)
Kim, Kyeong-Man (College of Pharmacy, Chonnam National University)
Publication Information
Biomolecules & Therapeutics / v.30, no.2, 2022 , pp. 191-202 More about this Journal
Abstract
Tetrazoles were designed and synthesized as potential inhibitors of triple monoamine neurotransmitters (dopamine, norepinephrine, serotonin) reuptake based on the functional and docking simulation of compound 6 which were performed in a previous study. The compound structure consisted of a tetrazole-linker (n)-piperidine/piperazine-spacer (m)-phenyl ring, with tetrazole attached to two phenyl rings (R1 and R2). Altering the carbon number in the linker (n) from 3 to 4 and in the spacer (m) from 0 to 1 increased the potency of serotonin reuptake inhibition. Depending on the nature of piperidine/piperazine, the substituents at R1 and R2 exerted various effects in determining their inhibitory effects on monoamine reuptake. Docking study showed that the selectivity of tetrazole for different transporters was determined based on multiple interactions with various residues on transporters, including hydrophobic residues on transmembrane domains 1, 3, 6, and 8. Co-expression of dopamine transporter, which lowers dopamine concentration in the biophase by uptaking dopamine into the cells, inhibited the dopamine-induced endoctytosis of dopamine D2 receptor. When tested for compound 40 and 56, compound 40 which has more potent inhibitory activity on dopamine reuptake more strongly disinhibited the inhibitory activity of dopamine transporter on the endocytosis of dopamine D2 receptor. Overall, we identified candidate inhibitors of triple monoamine neurotransmitter reuptake and provided a theoretical background for identifying such neurotransmitter modifiers for developing novel therapeutic agents of various neuropsychiatric disorders.
Keywords
Tetrazoles; Triple reuptake; Transporter; Structure-activity relationship; Docking simulation; Receptor endocytosis;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Kulkarni, S. K. and Dhir, A. (2009) Current investigational drugs for major depression. Expert Opin. Investig. Drugs 18, 767-788.   DOI
2 Le Bourdonnec, B., Meulon, E., Yous, S., Goossens, J. F., Houssin, R. and Henichart, J. P. (2000) Synthesis and pharmacological evaluation of new pyrazolidine-3, 5-diones as AT(1) angiotensin II receptor antagonists. J. Med. Chem. 43, 2685-2697.   DOI
3 Kim, K. M., Valenzano, K. J., Robinson, S. R., Yao, W. D., Barak, L. S. and Caron, M. G. (2001) Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and betaarrestins. J. Biol. Chem. 276, 37409-37414.   DOI
4 Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E. and Simmerling, C. (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J. Chem. Theory Comput. 11, 3696-3713.   DOI
5 Abraham, M. J., Murtola, T., Schulz, R., Pall, S., Smith, J. C., Hess, B. and Lindahl, E. (2015) GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19-25.   DOI
6 Gao, Y. L., Zhao, G. L., Liu, W., Shao, H., Wang, Y. L., Xu, W. R., Tang, L. D. and Wang, J. W. (2010) Design, synthesis and in vivo hypoglycemic activity of tetrazole-bearing N-glycosides as SGLT2 inhibitors. Indian. J. Chem. 49B, 1499-1508.
7 John, E. O., Kirchmeier, R. L. and Shreeve, J. M. (1989) Reactions of 5-(perfluoroalkyl)tetrazolates with cyanogen, nitrosyl, and cyanuric chlorides. Inorg. Chem. 28, 4629-4633.   DOI
8 Jorgensen, W. L., Chandrasekhar, J. and Madura, J. D. (1983) Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926.   DOI
9 Masson, J., Sagne, C., Hamon, M. and El Mestikawy, S. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439-464.
10 Laskowski, R. A. and Swindells, M. B. (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51, 2778-2786.   DOI
11 Singh, H., Chawla, A. S., Kapoor, V. K., Paul, D. and Malhotra, R. K. (1980) Medicinal chemistry of tetrazoles. Prog. Med. Chem. 17, 151-183.   DOI
12 Yu, S. S., Lefkowitz, R. J. and Hausdorff, W. P. (1993) Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J. Biol. Chem. 268, 337-341.   DOI
13 Subbaiah, M. A. M. (2018) Triple reuptake inhibitors as potential therapeutics for depression and other disorders: design paradigm and developmental challenges. J. Med. Chem. 61, 2133-2165.   DOI
14 Klapotke, T. M., Stierstorfer, J. and Weber, B. (2009) New energetic materials: synthesis and characterization of copper 5-nitriminotetrazolates. Inorg. Chim. Acta 362, 2311-2320.   DOI
15 Prins, J., Olivier, B. and Korte, S. M. (2011) Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opin. Investig. Drugs 20, 1107-1130.   DOI
16 Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R. and Schwede, T. (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296-W303.   DOI
17 Zhang, X. and Kim, K. M. (2017) Multifactorial regulation of G protein-coupled receptor endocytosis. Biomol. Ther. (Seoul) 25, 26-43.   DOI
18 Trott, O. and Olson, A. J. (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455-461.   DOI
19 Wang, K. H., Penmatsa, A. and Gouaux, E. (2015) Neurotransmitter and psychostimulant recognition by the dopamine transporter. Nature 521, 322-327.   DOI
20 Xue, W., Wang, P., Tu, G., Yang, F., Zheng, G., Li, X., Li, X., Chen, Y., Yao, X. and Zhu, F. (2018) Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder. Phys. Chem. Chem. Phys. 20, 6606-6616.   DOI
21 El-Sayed, W. A., El-Kosy, S. M., Ali, O. M., Emselm, H. M. and Abdel-Rahman, A. A. (2012) Anticancer activity of new (tetrazol-5-yl)methylindole derivatives and their acyclic c-nucleoside analogs. Acta Pol. Pharm. 69, 669-677.
22 Vieira, E., Huwyler, J., Jolidon, S., Knoflach, F., Mutel, V. and Wichmann, J. (2005) 9H-Xanthene-9-carboxylic acid [1,2,4]oxadiazol3-yl- and (2H-tetrazol-5-yl)-amides as potent, orally available mGlu1 receptor enhancers. Bioorg. Med. Chem. Lett. 15, 4628-4631.   DOI
23 Wagle, S., Adhikari, A. V. and Kumari, N. S. (2009) Synthesis of some new 4-styryltetrazolo[1,5-a]quinoxaline and 1-substituted4-styryl[1,2,4]triazolo[4,3-a]quinoxaline derivatives as potent anticonvulsants. Eur. J. Med. Chem. 44, 1135-1143.   DOI
24 Wagner, D., Wellmer, F., Dilks, K., William, D., Smith, M. R., Kumar, P. P., Riechmann, J. L., Greenland, A. J. and Meyerowitz, E. M. (2004) Floral induction in tissue culture: a system for the analysis of LEAFY-dependent gene regulation. Plant J. 39, 273-282.   DOI
25 Dhayanithi, V., Shafi Syed, S., Kumaran, K., Jai Sankar, K. R., Ragavan Venkat, R., Goud Kumar Sanath, P., Kumari Suchetha, N. and Pati Hari, N. (2011) Synthesis of selected 5-thio-substituted tetrazole derivatives and evaluation of their antibacterial and antifungal activities. J. Serb. Chem. Soc. 76, 165-175.   DOI
26 Burger, A. (1991) Isosterism and bioisosterism in drug design. Prog. Drug Res. 37, 287-371.
27 Cho, D., Zheng, M., Min, C., Ma, L., Kurose, H., Park, J. H. and Kim, K. M. (2010) Agonist-induced endocytosis and receptor phosphorylation mediate resensitization of dopamine D(2) receptors. Mol. Endocrinol. 24, 574-586.   DOI
28 Hess, B., Bekker, H., Berendsen, H. J. C. and Fraaije, J. G. E. M. (1997) LINCS: a linear constraint solver for molecular simulations. J. Comput. Chem. 18, 1463-1472.   DOI
29 Coleman, J. A., Green, E. M. and Gouaux, E. (2016) X-ray structures and mechanism of the human serotonin transporter. Nature 532, 334-339.   DOI
30 Dahlof, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., De Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L. H., Nieminen, M. S., Omvik, P., Oparil, S. and Wedel, H.; LIFE Study Group (2002) Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 359, 995-1003.   DOI
31 Herr, R. J. (2002) 5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods. Bioorg. Med. Chem. 10, 3379-3393.   DOI
32 Hirschfeld, R. M. (2000) History and evolution of the monoamine hypothesis of depression. J. Clin. Psychiatry 61 Suppl 6, 4-6.   DOI
33 Holtzheimer, P. E., 3rd and Nemeroff, C. B. (2006) Advances in the treatment of depression. NeuroRx 3, 42-56.   DOI
34 Hutchinson, D. W. and Naylor, M. (1985) The antiviral activity of tetrazole phosphonic acids and their analogues. Nucleic Acids Res. 13, 8519-8530.   DOI
35 Rajasekaran, A. and Thampi, P. P. (2004) Synthesis and analgesic evaluation of some 5-[beta-(10-phenothiazinyl)ethyl]-1-(acyl)-1,2,3,4-tetrazoles. Eur. J. Med. Chem. 39, 273-279.   DOI
36 Mosmann, T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.   DOI
37 Paudel, S., Cao, Y., Guo, S., An, B., Kim, K. M. and Cheon, S. H. (2015) Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors. Bioorg. Med. Chem. 23, 6418-6426.   DOI
38 Pegklidou, K., Koukoulitsa, C., Nicolaou, I. and Demopoulos, V. J. (2010) Design and synthesis of novel series of pyrrole based chemotypes and their evaluation as selective aldose reductase inhibitors. A case of bioisosterism between a carboxylic acid moiety and that of a tetrazole. Bioorg. Med. Chem. 18, 2107-2114.   DOI
39 Sorensen, L., Andersen, J., Thomsen, M., Hansen, S. M., Zhao, X., Sandelin, A., Stromgaard, K. and Kristensen, A. S. (2012) Interaction of antidepressants with the serotonin and norepinephrine transporters: mutational studies of the S1 substrate binding pocket. J. Biol. Chem. 287, 43694-43707.   DOI
40 Ichikawa, T., Kitazaki, T., Matsushita, Y., Hosono, H., Yamada, M., Mizuno, M. and Itoh, K. (2000) Optically active antifungal azoles. XI. An alternative synthetic route for 1-[(1R, 2R)-2-(2, 4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1, 2, 4-triazol-1-yl)propyl]-3-[4-(1H-1-tetrazolyl)phenyl]-2-imidazolidinone (TAK-456) and its analog. Chem. Pharm. Bull. 48, 1947-1953.   DOI
41 ChemAxon (2014) MarvinSketch (version 6.2.2), calculation module developed by ChemAxon. Available from: http://www.chemaxon.com/products/marvin/marvinsketch/.
42 Paudel, S., Kim, E., Zhu, A., Acharya, S., Min, X., Cheon, S. H. and Kim, K. M. (2021) Structural requirements for modulating 4-benzylpiperidine carboxamides from serotonin/norepinephrine reuptake inhibitors to triple reuptake inhibitors. Biomol. Ther. (Seoul) 29, 392-398.   DOI
43 Iversen, L. (2006) Neurotransmitter transporters and their impact on the development of psychopharmacology. Br. J. Pharmacol. 147 Suppl 1, S82-S88.   DOI
44 Torres, G. E., Yao, W. D., Mohn, A. R., Quan, H., Kim, K. M., Levey, A. I., Staudinger, J. and Caron, M. G. (2001) Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1. Neuron 30, 121-134.   DOI
45 Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C. and Ferrin, T. E. (2004) UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605-1612.   DOI
46 Belmaker, R. H. and Agam, G. (2008) Major depressive disorder. N. Engl. J. Med. 358, 55-68.   DOI
47 Martirosyan, A. O., Aleksanyan, M. V., Terzyan, S. S., Ter-Zakharyan, Y. Z., Agababyan, R. V., Karapetyan, A. A., Mndzhoyan, S. L. and Tamazyan, R. A. (2001) Synthesis and molecular and crystal structure of 1-(5-benzyl-2-tetrazolyl)-1-cyclopentanecarboxylic acid. penicillin and cephalosporins based on this acid. Pharm. Chem. J. 35, 169-171.   DOI
48 Paudel, S., Acharya, S., Yoon, G., Kim, K. M. and Cheon, S. H. (2017a) Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors. Bioorg. Med. Chem. 25, 2266-2276.   DOI
49 Paudel, S., Min, X., Acharya, S., Khadka, D. B., Yoon, G., Kim, K. M. and Cheon, S. H. (2017b) Triple reuptake inhibitors: design, synthesis and structure-activity relationship of benzylpiperidinetetrazoles. Bioorg. Med. Chem. 25, 5278-5289.   DOI
50 Sprenger, K. G., Jaeger, V. W. and Pfaendtner, J. (2015) The general AMBER force field (GAFF) can accurately predict thermodynamic and transport properties of many ionic liquids. J. Phys. Chem. B 119, 5882-5895.   DOI